Lattice Biologics Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
93.46 M |
Public Float |
- |
Lattice Biologics Ltd. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.01 |
Market Cap |
CAD2.4 M |
Shares Outstanding |
93.46 M |
Public Float |
- |
Address |
512 East Madison Avenue Belgrade Montana 59714 United States |
Employees | - |
Website | http://www.latticebiologics.com |
Updated | 07/08/2019 |
Lattice Biologics, Ltd. is a biotech company which engages in cellular therapies and tissue engineering, with a focus on bone, skin, and cartilage regeneration. Its products include allograft amniotic fluid viscosupplement, traditional allografts, spinal allografts, particulate allografts, soft tissue allografts, dental allografts, membrane and barrier allografts, and demineralized bone matrix allografts. The company is headquartered in Scottsdale, AZ. |